Skip to content

Multicenter study for artificial intelligence multimodal ultrasound in breast cancer

Multicenter study for artificial intelligence multimodal ultrasound in breast cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023566
Enrollment
Unknown
Registered
2019-06-02
Start date
2019-05-24
Completion date
Unknown
Last updated
2019-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Gold Standard:Pathological diagnosis
Index test:Ultrasound&#32
data&#32
and&#32
artificial&#32
intelligence&#32

Sponsors

Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. patients aged 18 to 80 years; 2. have only one breast mass; 3. The acquired image should be able to include normal tissue in the 1.0 cm range of the edge of the lump; 4. patients with breast mass resection or biopsy, and the exact pathological results can be obtained; 5. Target lumps have not been subjected to invasive procedures such as puncture, angiography, thermal ablation, and Mammoto.

Exclusion criteria

Exclusion criteria: 1. image data or pathological data is incomplete; 2. patients with multiple breast lumps; 3. after neoadjuvant chemotherapy; 4. halfway for various reasons to withdraw.

Design outcomes

Primary

MeasureTime frame
accuracy rate;Specificity;Sensitivity;

Countries

China

Contacts

Public ContactJiawei Tian

Second Affiliated Hospital of Harbin Medical University

jwtian2004@163.com+86 18686822228

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026